Registro:

Referencias:

• Aaronson, D.S., Horvath, C.M., A road map for those who don't know JAK-STAT (2002) Science, 296, pp. 1653-1655
• Aguet, M., Dembic, Z., Merlin, G., Molecular cloning and expression of the human interferon-gamma receptor (1988) Cell, 55, pp. 273-280
• Arzt, E., gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways (2001) Journal of Clinical Investigation, 108, pp. 1729-1733
• Auernhammer, C.J., Melmed, S., Leukemia-inhibitory factor-neuroimmune modulator of endocrine function (2000) Endocrine Reviews, 21, pp. 313-345
• Auernhammer, C.J., Chesnokova, V., Bousquet, C., Melmed, S., Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion (1998) Molecular Endocrinology, 12, pp. 954-961
• Belardelli, F., Role of interferons and other cytokines in the regulation of the immune response (1995) Acta Pathologica, Microbiologica. et Immunologica Scandinavica, 103, pp. 161-179
• Besedovsky, H.O., del Rey, A., Immune-neuro-endocrine interactions: Facts and hypotheses (1996) Endocrine Reviews, 17, pp. 64-102
• Billiau, A., Interferon-gamma: Biology and role in pathogenesis (1996) Advances in Immunology, 62, pp. 61-130
• Boehm, U., Klamp, T., Groot, M., Howard, J.C., Cellular responses to interferon-gamma (1997) Annual Review of Immunology, 15, pp. 749-795
• Bousquet, C., Melmed, S., Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling (1999) Journal of Biological Chemistry, 274, pp. 10723-10730
• Bousquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immunoneurciendocrine interfacing (2000) Journal of Clinical Investigation, 106, pp. 1417-1425
• Boutillier, A.L., Monnier, D., Lorang, D., Lundblad, J.R., Roberts, J.L., Loeffler, J.P., Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: Characterization of an AP1 site in exon 1 (1995) Molecular Endocrinology, 9, pp. 745-755
• Boutillier, A.L., Gaiddon, C., Lorang, D., Roberts, J.L., Loeffler, J.P., Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein (1998) Pituitary, 1, pp. 33-43
• Bromberg, J., Star proteins and oncogenesis (2002) Journal of Clinical Investigation, 109, pp. 1139-1142
• Bromberg, J.F., Horvath, C.M., Wen, Z., Schreiber, R.D., Darnell Jr, J.E., Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon ganum (1996) PNAS, 93, pp. 7673-7678
• Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell Jr, J.E., Stat3 as an oncogene (1999) Cell, 98, pp. 295-303
• Buszello, H., Antiproliferative effects of four diferent cytokines on renal carcinoma cell lines (1995) Anticancer Research, 15, pp. 735-738
• Calo, V., Mighavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., Russo, A., STAT proteins: From normal control of cellular events to tumorigenesis (2003) Journal of Cellular Physiology, 197, pp. 157-168
• Chew, L.J., King, W.C., Kennedy, A., Gallo, V., Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells (2005) Glia, 52, pp. 127-143
• Chin, Y.E., Kitagawa, M., Su, W.C., You, Z.H., Iwamoto, Y., Fu, X.Y., Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1 (1996) Science, 272, pp. 719-722
• Darnell Jr, J.E., STATs and gene regulation (1997) Science, 277, pp. 1630-1635
• Deb, A., Haque, S.J., Mogensen, T., Silverman, R.H., Williams, B.R., RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway (2001) Journal of Immunology, 166, pp. 6170-6180
• Gagner, J.P., Drouin, J., Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate, and glucocorticoids (1987) Molecular Endocrinology, 1, pp. 677-682
• Ganster, K.W., Guo, Z., Shao, L., Geller, D.A., Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions (2005) Journal of Interferon & Cytokine Research, 25, pp. 707-719
• Giacomini, D., Paez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Buchfelder, M., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147, pp. 247-256
• Gutierrez, H., Hale, V.A., Dolcet, X., Davies, A., NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS (2005) Development, 132, pp. 1713-1726
• Harvat, B.L., Seth, P., Jetten, A.M., The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells (1997) Oncogene, 14, pp. 2111-2122
• Hemmi, S., Bohni, R., Stark, G., Di Marco, F., Aguet, M., A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells (1994) Cell, 76, pp. 803-810
• Holsboer, F., Stalla, G.K., von Bardeleben, U., Hammann, K., Muller, H., Muller, O.A., Acute adrenocortical stimulation by recombinant gamma interferon in human controls (1988) Life Sciences, 42, pp. 1-5
• Horvath, C.M., Wen, Z., Darnell Jr, J.E., A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain (1995) Genes and Development, 9, pp. 984-994
• Ikeda, H., Old, L.J., Schreiber, R.D., The roles of IFN gamma in protection against tumor development and cancer immunoediting (2002) Cytokine and Growth Factor Reviews, 13, pp. 95-109
• Karalis, K.P., Venihaki, M., Zhao, J., van Vlerken, L.E., Chandras, C., NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene (2004) Journal of Biological Chemistry, 279, pp. 10837-10840
• Katahira, M., Iwasaki, Y., Aoki, Y., Oiso, Y., Saito, H., Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells (1998) Endocrinology, 139, pp. 2414-2422
• Kovalovsky, D., Refojo, D., Liberman, A.C., Hochbaum, D., Pereda, M.P., Coso, O.A., Stalla, G.K., Arzt, E., Activation and induction of NUR77/ NURR1 in corticotrophs by CRH/cAMP: Involvement of calcium, protein kinase A, and MAPK pathways (2002) Molecular Endocrinology, 16, pp. 1638-1651
• Kumar, C.S., Muthukumaran, G., Frost, L.J., Noe, M., Ahn, Y.H., Mariano, T.M., Pestka, S., Molecular characterization of the murine interferon gamma receptor cDNA (1989) Journal of Biological Chemistry, 264, pp. 17939-17946
• Lamolet, B., Pulichino, A.M., Lamonerie, T., Gauthier, Y., Brue, T., Enjalbert, A., Drouin, J., A pituitary cell-restricted T box factor, Tpit, activates Pomc transcription in cooperation with Pitx homeoproteins (2001) Cell, 104, pp. 849-859
• Levin, N., Blum, M., Roberts, J.L., Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary (1989) Endocrinology, 125, pp. 2957-2966
• Levy, D.E., Darnell Jr, J.E., Stats: Transcriptional control and biological impact (2002) Nature Reviews. Molecular Cell Biology, 3, pp. 651-662
• Liu, B., Mortrud, M., Low, M.J., DNA elements with AT-rich core sequences direct pituitary cell-specific expression of the pro-opiomelanocortin gene in transgenic mice (1995) Biochemical Journal, 312, pp. 827-832
• Lundblad, J.R., Roberts, J.L., Regulation of proopiomelanocortin gene expression in pituitary (1988) Endocrine Reviews, 9, pp. 135-158
• Maira, M., Martens, C., Philips, A., Drouin, J., Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation (1999) Molecular and Cellular Biology, 19, pp. 7549-7557
• Mandal, M., Bandyopadhyay, D., Goepfert, T.M., Kumar, R., Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK) (1998) Oncogene, 16, pp. 217-225
• Marks-Konczalik, J., Chu, S.C., Moss, J., Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites (1998) Journal of Biological Chemistry, 273, pp. 22201-22208
• Murphy, E.P., Conneely, O.M., Neuroendocrine regulation of the hypothalamic-pituitary-adrenal aids by the nurr1/nur77 subfamily of nuclear receptors (1997) Molecular Endocrinology, 11, pp. 39-47
• Mynard, V., Guignat, L., Devin-Leclerc, J., Bertagna, X., Catelli, M.G., Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions (2002) Endocrinology, 143, pp. 3916-3924
• Mynard V, Latchoumanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barre B, Fagart J, Coqueret O & Catelli MG 2004 Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3′,5′-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter. Molecular Endocrinology 18 2997-3010; Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Hirano, T., A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells (1996) EMBO Journal, 15, pp. 3651-3658
• Nudi, M., Ouimette, J.F., Drouin, J., Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity (2005) Molecular Endocrinology, 19, pp. 1329-1342
• Paez-Pereda, M., Ledda, M.F., Goldberg, V., Chervin, A., Carrizo, G., Molina, H., Muller, A., Arzt, E., High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 263-269
• Paez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Missale, C., Retinoic acid prevents experimental Cushing syndrome (2001) Journal of Clinical Investigation, 108, pp. 1123-1131
• Philips, A., Lesage, S., Gingras, R., Maira, M.H., Gauthier, Y., Hugo, P., Drouin, J., Novel dimeric NUR77 signaling mechanism in endocrine and lymphoid cells (1997) Molecular and Cellular Biology, 17, pp. 5946-5951
• Philips, A., Maira, M., Mullick, A., Chamberland, M., Lesage, S., Hugo, P., Drouin, J., Antagonism between NUR77 and glucocorticoid receptor for control of transcription (1997) Molecular and Cellular Biology, 17, pp. 5952-5959
• Pitossi, F., del Rey, A., Kabiersch, A., Besedovsky, H., Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice (1997) Journal of Neuroscience Research, 48, pp. 287-298
• Platanias, L.C., Mechanisms of type-I- and type-II-interferon-mediated signalling (2005) Nature Reviews. Immunology, 5, pp. 375-386
• Qing, Y., Stark, G.R., Alternative activation of STAT1 and STAT3 in response to interferon-gamma (2004) Journal of Biological Chemistry, 279, pp. 41679-41685
• Ramana, C.V., Gil, M.P., Schreiber, R.D., Stark, G.R., Stat1-dependent and - independent pathways in IFN-gamma-dependent signaling (2002) Trends in Immunology, 23, pp. 96-101
• Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocrine Reviews, 18, pp. 206-228
• Saiki, I., Sato, K., Yoo, Y.C., Murata, J., Yoneda, J., Kiso, M., Hasegawa, A., Azuma, I., Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-gamma followed by a synthetic lipid-A subunit analogue (GLA-60) (1992) International Journal of Cancer, 51, pp. 641-645
• Schindler, C., Darnell Jr, J.E., Transcriptional responses to polypeptide ligands: The JAK-STAT pathway (1995) Annual Review of Biochemistry, 64, pp. 621-651
• Schindler, C.W., Series introduction. JAK-STAT signaling in human disease (2002) Journal of Clinical Investigation, 109, pp. 1133-1137
• Seidel, H.M., Milocco, L.H., Lamb, P., Darnell Jr, J.E., Stein, R.B., Rosen, J., Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity (1995) PNAS, 92, pp. 3041-3045
• Sizemore, N., Agarwal, A., Das, K., Lerner, N., Sulak, M., Rani, S., Ransohoff, R., Stark, G.R., Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes (2004) PNAS, 101, pp. 7994-7998
• Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Nicola, N.A., A family of cytokine-inducible inhibitors of signalling (1997) Nature, 387, pp. 917-921
• Suk, K., Chang, I., Kim, Y.H., Kim, S., Kim, J.Y., Kim, H., Lee, N.I.S., Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways (2001) Journal of Biological Chemistry, 276, pp. 13153-13159
• Utsuyama, M., Hirokawa, K., Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice (2002) Experimental Gerontology, 37, pp. 411-420
• Vankelecom, H., Carmeliet, P., Heremans, H., Van Damme, J., Dijkmans, R., Billiau, A., Denef, C., Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures (1990) Endocrinology, 126, pp. 2919-2926
• Vankelecom, H., Andries, M., Billiau, A., Denef, C., Evidence that folliculostellate cells mediate the inhibitory effect of interferon-gamma on hormone secretion in rat anterior pituitary cell cultures (1992) Endocrinology, 130, pp. 3537-3546
• Wall, L., Burke, F., Smyth, J.F., Balkwill, F., The anti-proliferative activity of interferon-gamma on ovarian cancer: In vitro and in vivo (2003) Gynecologic Oncology, 88, pp. S149-S151
• Wen, Z., Zhong, Z., Darnell Jr, J.E., Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation (1995) Cell, 82, pp. 241-250
• Wu, A.J., Chen, Z.J., Tsokos, M., O'Connell, B.C., Ambudkar, I.S., Baum, B.J., Interferon-gamma induced cell death in a cultured human salivary gland cell line (1996) Journal of Cellular Physiology, 167, pp. 297-304
• Yamaguchi, M., Koike, K., Matsuzaki, N., Yoshimoto, Y., Taniguchi, T., Miyake, A., Tanizawa, O., The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro (1991) Journal of Endocrinological Investigation, 14, pp. 457-461
• Zhong, Z., Wen, Z., Darnell Jr, J.E., Stat3 and Stat4: Members of the family of signal transducers and activators of transcription (1994) PNAS, 91, pp. 4806-4810

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------